Package 54092-701-04

Brand: vpriv

Generic: velaglucerase alfa
NDC Package

Package Facts

Identity

Package NDC 54092-701-04
Digits Only 5409270104
Product NDC 54092-701
Product ID 54092-701_27f96d8e-a6e0-4743-a76c-00f979bfb5f7
Description

1 VIAL, GLASS in 1 BOX (54092-701-04) / 4 mL in 1 VIAL, GLASS

Marketing

Marketing Status
Marketed Since 2010-02-26
Brand vpriv
Generic velaglucerase alfa
Sample Package No

Linked Drug Pages (1)

VPRIV ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "27f96d8e-a6e0-4743-a76c-00f979bfb5f7", "openfda": {"nui": ["N0000175820"], "unii": ["23HYE36B0I"], "rxcui": ["901808", "901812"], "spl_set_id": ["ca02f7a4-ae4f-43c1-a06a-259fe4fcf9cf"], "pharm_class_epc": ["Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 BOX (54092-701-04)  / 4 mL in 1 VIAL, GLASS", "package_ndc": "54092-701-04", "marketing_start_date": "20100226"}], "brand_name": "VPRIV", "product_id": "54092-701_27f96d8e-a6e0-4743-a76c-00f979bfb5f7", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]"], "product_ndc": "54092-701", "generic_name": "velaglucerase alfa", "labeler_name": "Takeda Pharmaceuticals America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VPRIV", "active_ingredients": [{"name": "VELAGLUCERASE ALFA", "strength": "2.5 mg/mL"}], "application_number": "BLA022575", "marketing_category": "BLA", "marketing_start_date": "20100226", "listing_expiration_date": "20261231"}